"NF-kappa B p50 Subunit" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A component of NF-kappa B transcription factor. It is proteolytically processed from NF-kappa B p105 precursor protein and is capable of forming dimeric complexes with itself or with TRANSCRIPTION FACTOR RELA. It regulates expression of GENES involved in immune and inflammatory responses.
| Descriptor ID |
D052002
|
| MeSH Number(s) |
D12.776.260.600.124 D12.776.660.600.124 D12.776.930.600.124
|
| Concept/Terms |
NF-kappa B p50 Subunit- NF-kappa B p50 Subunit
- NF kappa B p50 Subunit
- NFKB1 Transcription Factor
- Transcription Factor, NFKB1
- NF-kappa B p50
- NF kappa B p50
- p50, NF-kappa B
- NF-kappaB 50-kDa
- NF kappaB 50 kDa
|
Below are MeSH descriptors whose meaning is more general than "NF-kappa B p50 Subunit".
Below are MeSH descriptors whose meaning is more specific than "NF-kappa B p50 Subunit".
This graph shows the total number of publications written about "NF-kappa B p50 Subunit" by people in this website by year, and whether "NF-kappa B p50 Subunit" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 1 | 0 | 1 |
| 2017 | 1 | 1 | 2 |
| 2018 | 2 | 2 | 4 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "NF-kappa B p50 Subunit" by people in Profiles.
-
PCA-based unsupervised feature extraction for gene expression analysis of COVID-19 patients. Sci Rep. 2021 08 30; 11(1):17351.
-
A Computational Approach Identified Andrographolide as a Potential Drug for Suppressing COVID-19-Induced Cytokine Storm. Front Immunol. 2021; 12:648250.
-
Fluoxetine as an anti-inflammatory therapy in SARS-CoV-2 infection. Biomed Pharmacother. 2021 Jun; 138:111437.
-
Can bilirubin nanomedicine become a hope for the management of COVID-19? Med Hypotheses. 2021 Apr; 149:110534.
-
Entropy-driven electrochemiluminescence ultra-sensitive detection strategy of NF-?B p50 as the regulator of cytokine storm. Biosens Bioelectron. 2021 Mar 15; 176:112942.
-
EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2. PLoS One. 2020; 15(11):e0241739.
-
Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin. Med Hypotheses. 2020 Oct; 143:110111.
-
Common Variable Immunodeficiency with Genetic Defects Identified by Whole Exome Sequencing. Biomed Res Int. 2018; 2018:3724630.
-
Crosstalk of NF-?B/P65 and LncRNA HOTAIR-Mediated Repression of MUC1 Expression Contribute to Synergistic Inhibition of Castration-Resistant Prostate Cancer by Polyphyllin 1-Enzalutamide Combination Treatment. Cell Physiol Biochem. 2018; 47(2):759-773.
-
Involvement of HIF-1a-regulated miR-21, acting via the Akt/NF-?B pathway, in malignant transformation of HBE cells induced by cigarette smoke extract. Toxicol Lett. 2018 Jun 01; 289:14-21.